Medicinova Inc (MNOV) Directors and Executive Officers - CSIMarket
CSIMarket
 
Medicinova Inc   (NASDAQ: MNOV)

Medicinova Inc

Officers & Directors


Jason Kruger
Chief Financial Officer - (Principal financial and accounting officer)

Kazuko Matsuda
Director

BDO USA, P.C.
We have served as the - Company

Yuichi Iwaki, M.D., Ph.D.
Chairman of the Board of Directors, President and Chief Executive Officer - (Principal executive officer)
President

Carolyn Beaver
Director

Nicole Lemerond
Director

Hideki Nagao
Director ,

Medicinova Inc currently has 6 employees.

  News about Medicinova Inc Key Personnel

MediciNova on the Brink: Navigating Legal Settlements and Clinical Ambitions Amid Financial Strains

In a noteworthy turn of events for MediciNova, Inc. a biopharmaceutical company based in La Jolla, California, the firm has received notification regarding monetary damages stemming from a patent settlement involving Sanofi and Novartis. This development, announced on November 11, 2024, indicates that MediciNova stands to gain a financial boost from this settlement, although specific figures remain undisclosed. However, the company’s financial landscape appears tumultuous as it faces a significant cumulative net loss of $8 million over the twelve months leading into the second quarter of 2024. This financial struggle has resulted in a negative return on assets (ROA) of -13.32%. In a crowded healthcare mark...






MNOV Management Effectiveness MNOV Revenue per Employee MNOV Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.